50 likes | 61 Views
Global Cancer Diagnostics Market is expected to grow at a CAGR of 9.5% during the forecast period 2020-2025. The market is segmented into Types, Applications (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancers, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, and Other Cancers), End User, and Region. A research report by Foster Market Research provides deep market insight that will help your business to grow with an improved go-to-market business strategy.
E N D
Important Thing Need To Know About Upcoming Cancer Diagnostics Market In 2025 The global cancer diagnostics market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and it is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Cancer diagnostics refers to the techniques deployed for diagnosing cancer. A range of imaging techniques is used for diagnosing cancer, including bone scan, computerized tomography (CT) scan, ultrasound and X-ray, positron emission tomography (PET) scan, and magnetic resonance imaging (MRI), among others. Technological advancements, initiatives adopted by government worldwide and global health organizations to develop awareness about cancer, rising prevalence of cancer, rise in the number of private diagnostics centers, public-private partnerships to boost infrastructure of diagnostic imaging centers, and FDA (Food and Drug Administration) support for biomarker development and introduction of novel flow cytometry reagents for drug discovery and diagnostics have increased the demand for the cancer diagnostics market. Key Insights: Latest Updates Analyst Views Future Outlook of the Market ● ● ● Get Free PDF Brochure of this Report @ https://www.fostermarketresearch.com/product/industry/clinical-diagnostic/ global-cancer-diagnostics-market/Pdf%20Brochure/ Competitive Landscape: Key players in global cancer diagnostics market include Exact Sciences Corporation, Arquer Diagnostics Ltd., BioMark Diagnostics Inc., Biotheranostics, Cancer Diagnostics, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Becton, Dickinson and Company (BD), GE Healthcare, QIAGEN N.V., Abbott Laboratories, Inc., Roche Diagnostics, Siemens Healthcare, and Koninklijke Philips N.V., Inc., among others. The market is competitive with several small and medium enterprises (SMEs). The major strategy adopted by the SME is acquisition to gain the market share. For instance, in July 2020 Eurobio Scientific acquired TECO medical AG, which is specialized in the
development and distribution of in-vitro diagnostic tests in Europe, and it has operations across Austria, Germany, Switzerland, and Benelux. Market Taxonomy: By Type Platform-Based Diagnostics ○ Polymerase Chain Reaction (PCR) ○ in Situ Hybridization, (ISH) ○ Immunohistochemistry (ICH) ○ Next-Generation Sequencing (NGS) ○ Microarrays ○ Flow Cytometry ○ Other Technologies Instrument-Based ○ Diagnostic Imaging ■ Magnetic Resonance Imaging (MRI) ■ Computed Tomography (CT) ■ Positron Emission Tomography (PET) ■ Standalone Positron Emission Tomography ■ Hybrid Positron Emission Tomography ■ Mammography ■ Ultrasound ○ Biopsies ○ Immunohistochemistry ○ In Situ Hybridization ○ Tumor Biomarkers Tests ■ PSA Tests ■ CTC Tests ■ AFP Tests ■ CA-19 Tests ■ HER2 Tests ■ BRCA Tests ■ ALK Tests ■ CEA Tests ■ EGFR Mutation Tests ■ KRAS Mutation Tests ■ Others ● ● By Application Breast Cancer Lung Cancer ● ●
Colorectal Cancer Melanoma Blood Cancers Prostate Cancer Ovarian Cancer Stomach Cancer Liver Cancer Other Cancers ● ● ● ● ● ● ● ● By End User Hospital Associated Labs Independent Diagnostic Laboratories Diagnostic Imaging Centers Cancer Research Institutes Others ● ● ● ● ● By Region North America Europe Asia-Pacific Latin America Middle East and Africa ● ● ● ● ● Get Free Sample of this Report @ https://www.fostermarketresearch.com/product/industry/clinical-diagnostic/ global-cancer-diagnostics-market/sample/ Market Dynamics: Technological advancements in cancer diagnostics have driven the market growth. For instance, according to the American Association for the Advancement of Science (AAAS) in June 2020 publication, researchers at Washington State University have developed an advanced technology that is expected to be over 30 times more sensitive compared to the existing lab-based tests in detection of cancer biomarkers at an early cancer stage in the blood. This technology deploys an electric field to concentrate and uniquely separate the cancer biomarkers on the paper strip. In addition, substantial government initiatives to boost cancer awareness among people are expected to encourage them to adopt early diagnosis of cancer practices thereby, contributing to market growth. For instance, according to the North Carolina government sources, in October 2019, the government of North Carolina has declared October as the month for Breast Cancer Awareness Month. However, the government’s breast and cervical cancer care program
(BCCCP) functions to screen women all through the year. Through BCCCP, the government of North Carolina offers free or low-cost colorectal screenings, breast screenings, and follow-up services for suitable women. These key factors drive the demand for early diagnosis of cancer and thereby boost the market growth. However, the high cost of diagnostics procedure for cancers acts as a restraint for cancer diagnostics market. FAQ's: Note: This report provides in-depth analysis of the global cancer diagnostics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year. What are the trends adopted by key players in the global cancer diagnostics market? What key factors are expected to increase the demand for cancer diagnostics market during the forecast period 2020-2025? What are the major challenges inhibiting the growth of the global cancer diagnostics market? What was the total market value (US$ Mn) generated in global cancer diagnostics market by type in 2019, and what are the forecasts by 2025? Which application contribute highest CAGR (%) in the cancer diagnostics market? Which end user is expected to dominate the cancer diagnostics market in the coming years? What was the total revenue generated by the global cancer diagnostics market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)? Who are the key players contributing to the growth of the global cancer diagnostics market, and what are the new strategies adopted by them to retain a market share in the industry? ● ● ● ● ● ● ● ● Buy Now This Business Strategic Report to Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/clinical-diagnostic/19/ About Foster Market Research: Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data. Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.
Contact Us: 1701 Royal Lane, #1306, Dallas Tx-75229 Phone: +1 469 4981929 Email: support@fostermarketresearch.com